{"id":"https://openalex.org/W2943333990","doi":"https://doi.org/10.1016/j.clcc.2019.04.006","title":"Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study","display_name":"Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study","publication_year":2019,"publication_date":"2019-05-03","ids":{"openalex":"https://openalex.org/W2943333990","doi":"https://doi.org/10.1016/j.clcc.2019.04.006","mag":"2943333990","pmid":"https://pubmed.ncbi.nlm.nih.gov/31311761"},"language":"en","primary_location":{"id":"doi:10.1016/j.clcc.2019.04.006","doi":"https://doi.org/10.1016/j.clcc.2019.04.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clcc.2019.04.006","pdf_url":"http://www.clinical-colorectal-cancer.com/article/S1533002818304547/pdf","source":{"id":"https://openalex.org/S112974357","display_name":"Clinical Colorectal Cancer","issn_l":"1533-0028","issn":["1533-0028","1938-0674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clinical Colorectal Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.clinical-colorectal-cancer.com/article/S1533002818304547/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022288769","display_name":"Christophe Borg","orcid":"https://orcid.org/0000-0002-2167-1458","observed_orcids":["https://orcid.org/0000-0002-2167-1458","https://orcid.org/0000-0001-6161-0169"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Christophe Borg","raw_affiliation_strings":["Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France. Electronic address: christophe.borg@efs.sante.fr","Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France. Electronic address: christophe.borg@efs.sante.fr","institution_ids":["https://openalex.org/I4210087978"]},{"raw_affiliation_string":"Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106486097","display_name":"Georges Mantion","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Georges Mantion","raw_affiliation_strings":["Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023530877","display_name":"Frank P. Boudghene","orcid":"https://orcid.org/0000-0003-2359-8853","observed_orcids":["https://orcid.org/0000-0003-2359-8853"]},"institutions":[{"id":"https://openalex.org/I4210166768","display_name":"H\u00f4pital Tenon","ror":"https://ror.org/05h5v3c50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210166768"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Frank Boudgh\u00e8ne","raw_affiliation_strings":["Department of Radiology, Tenon Hospital, Paris, France"],"raw_orcid":"https://orcid.org/0000-0003-2359-8853","affiliations":[{"raw_affiliation_string":"Department of Radiology, Tenon Hospital, Paris, France","institution_ids":["https://openalex.org/I4210166768"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022986634","display_name":"F. Mornex","orcid":"https://orcid.org/0000-0002-0234-1269","observed_orcids":["https://orcid.org/0000-0002-0234-1269"]},"institutions":[{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7oise Mornex","raw_affiliation_strings":["Department of Radiotherapy, Lyon-Sud Hospital Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy, Lyon-Sud Hospital Center, Lyon, France","institution_ids":["https://openalex.org/I4210113288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043463827","display_name":"Fran\u00e7ois Ghiringhelli","orcid":"https://orcid.org/0000-0002-5465-8305","observed_orcids":["https://orcid.org/0000-0002-5465-8305","https://orcid.org/0009-0000-3637-9479"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Ghiringhelli","raw_affiliation_strings":["Department of Medicine, Georges-Fran\u00e7ois-Leclerc Center, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Georges-Fran\u00e7ois-Leclerc Center, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026512478","display_name":"Antoine Adenis","orcid":"https://orcid.org/0000-0003-3123-9746","observed_orcids":["https://orcid.org/0000-0003-3123-9746"]},"institutions":[{"id":"https://openalex.org/I4210131356","display_name":"Centre Oscar Lambret","ror":"https://ror.org/03xfq7a50","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210131356","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Antoine Adenis","raw_affiliation_strings":["Department of Medical Oncology, Oscar Lambret Center, Lille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Oscar Lambret Center, Lille, France","institution_ids":["https://openalex.org/I4210131356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031202796","display_name":"D. Azria","orcid":"https://orcid.org/0000-0002-7533-2988","observed_orcids":["https://orcid.org/0000-0002-7533-2988"]},"institutions":[{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"David Azria","raw_affiliation_strings":["ICM Cancer Institute of Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICM Cancer Institute of Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I4210140335"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083672016","display_name":"Jacques Balosso","orcid":"https://orcid.org/0000-0003-0714-9003","observed_orcids":["https://orcid.org/0000-0003-0714-9003"]},"institutions":[{"id":"https://openalex.org/I4210140335","display_name":"Institut de Recherche en Canc\u00e9rologie de Montpellier","ror":"https://ror.org/03capj968","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210140335","https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jacques Balosso","raw_affiliation_strings":["ICM Cancer Institute of Montpellier, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICM Cancer Institute of Montpellier, Montpellier, France","institution_ids":["https://openalex.org/I4210140335"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005765894","display_name":"M\u00e9her Ben Abdelghani","orcid":"https://orcid.org/0000-0002-9105-6346","observed_orcids":["https://orcid.org/0000-0002-9105-6346"]},"institutions":[{"id":"https://openalex.org/I4405277693","display_name":"Institut Strauss","ror":"https://ror.org/03k1y0r37","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4405277693"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Meher Ben Abdelghani","raw_affiliation_strings":["Gastroenterologist, Paul Strauss Center, Strasbourg, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastroenterologist, Paul Strauss Center, Strasbourg, France","institution_ids":["https://openalex.org/I4405277693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061710022","display_name":"Jean\u2010Baptiste Bachet","orcid":"https://orcid.org/0000-0003-4337-286X","observed_orcids":["https://orcid.org/0000-0003-4337-286X"]},"institutions":[{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Baptiste Bachet","raw_affiliation_strings":["Gastroenterologist, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastroenterologist, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris, France","institution_ids":["https://openalex.org/I4210121705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038199519","display_name":"V. Vendrely","orcid":"https://orcid.org/0000-0001-8627-4616","observed_orcids":["https://orcid.org/0000-0001-8627-4616"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"V\u00e9ronique Vendrely","raw_affiliation_strings":["CHU Bordeaux, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111809985","display_name":"Yves Fran\u00e7ois","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yves Fran\u00e7ois","raw_affiliation_strings":["Department of Surgery, CHU Lyon Sud, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, CHU Lyon Sud, Lyon, France","institution_ids":["https://openalex.org/I4210113288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020997210","display_name":"Thierry Conroy","orcid":"https://orcid.org/0000-0001-7548-284X","observed_orcids":["https://orcid.org/0000-0001-7548-284X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thierry Conroy","raw_affiliation_strings":["Department of Medical Oncology, Lorraine Cancer Institute, Vand\u0153uvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Lorraine Cancer Institute, Vand\u0153uvre-l\u00e8s-Nancy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104010651","display_name":"Emmanuel Rio","orcid":"https://orcid.org/0000-0002-1785-6329","observed_orcids":["https://orcid.org/0000-0002-1785-6329"]},"institutions":[{"id":"https://openalex.org/I4210106090","display_name":"Institut de Canc\u00e9rologie de l'Ouest","ror":"https://ror.org/01m6as704","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210106090"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emmanuel Rio","raw_affiliation_strings":["Department of Radiotherapy Oncology, Institut de Canc\u00e9rologie de l'Ouest (ICO), Saint-Herblain, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy Oncology, Institut de Canc\u00e9rologie de l'Ouest (ICO), Saint-Herblain, France","institution_ids":["https://openalex.org/I4210106090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057401894","display_name":"Bernard Roullet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bernard Roullet","raw_affiliation_strings":["Department of Radiotherapy Oncology, CHU Poitiers, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy Oncology, CHU Poitiers, Poitiers, France","institution_ids":["https://openalex.org/I4210111187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108249703","display_name":"Dominique Spa\u00ebth","orcid":"https://orcid.org/0009-0004-3161-511X","observed_orcids":["https://orcid.org/0009-0004-3161-511X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dominique Spa\u00ebth","raw_affiliation_strings":["Department of Medical Oncology, Gentilly Oncology Center, Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Gentilly Oncology Center, Nancy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026121059","display_name":"L. Qu\u00e9ro","orcid":"https://orcid.org/0000-0002-8781-2540","observed_orcids":["https://orcid.org/0000-0002-8781-2540"]},"institutions":[{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Quero","raw_affiliation_strings":["Department of Radiotherapy Oncology, CHU Saint Louis, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiotherapy Oncology, CHU Saint Louis, Paris, France","institution_ids":["https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080296829","display_name":"Zaher Lakkis","orcid":"https://orcid.org/0000-0002-2608-5896","observed_orcids":["https://orcid.org/0000-0002-2608-5896"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Zaher Lakkis","raw_affiliation_strings":["Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital of Besan\u00e7on and CIC-BT506, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112076022","display_name":"Mathieu Coudert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107416","display_name":"Roche (France)","ror":"https://ror.org/01mqmer16","country_code":"FR","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210107416"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mathieu Coudert","raw_affiliation_strings":["Roche Laboratories, Boulogne-Billancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Laboratories, Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210107416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022988132","display_name":"Miruna Ionescu-Goga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107416","display_name":"Roche (France)","ror":"https://ror.org/01mqmer16","country_code":"FR","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210107416"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Miruna Ionescu-Goga","raw_affiliation_strings":["Roche Laboratories, Boulogne-Billancourt, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Laboratories, Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210107416"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018008316","display_name":"Alexandre Tanang","orcid":"https://orcid.org/0000-0002-4142-6011","observed_orcids":["https://orcid.org/0000-0002-4142-6011"]},"institutions":[{"id":"https://openalex.org/I4210107416","display_name":"Roche (France)","ror":"https://ror.org/01mqmer16","country_code":"FR","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210107416"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alexandre Tanang","raw_affiliation_strings":["Roche Laboratories, Boulogne-Billancourt, France"],"raw_orcid":"https://orcid.org/0000-0002-4142-6011","affiliations":[{"raw_affiliation_string":"Roche Laboratories, Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210107416"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079480540","display_name":"Thierry Andr\u00e9","orcid":"https://orcid.org/0000-0002-5103-7095","observed_orcids":["https://orcid.org/0000-0002-5103-7095"]},"institutions":[{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thierry Andr\u00e9","raw_affiliation_strings":["Department of Medical Oncology, Saint Antoine Hospital and Pierre et Marie Curie University, UMPC Paris, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Saint Antoine Hospital and Pierre et Marie Curie University, UMPC Paris, Paris, France","institution_ids":["https://openalex.org/I4210102928","https://openalex.org/I4405264447"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":15,"corresponding_author_ids":["https://openalex.org/A5022288769"],"corresponding_institution_ids":["https://openalex.org/I4210087978"],"apc_list":{"value":1900,"currency":"USD","value_usd":1900},"apc_paid":{"value":1900,"currency":"USD","value_usd":1900},"fwci":0.938,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.75666796,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"18","issue":"3","first_page":"200","last_page":"208.e1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13110","display_name":"Colorectal and Anal Carcinomas","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8069999814033508},{"id":"https://openalex.org/keywords/locally-advanced-rectal-cancer","display_name":"locally advanced rectal cancer","score":0.906000018119812},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/folfox4","display_name":"FOLFOX4","score":0.9120000004768372},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.843999981880188},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/total-mesorectal-excision","display_name":"total mesorectal excision","score":0.9869999885559082},{"id":"https://openalex.org/keywords/anastomotic-fistula","display_name":"anastomotic fistula","score":0.9089999794960022},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.878000020980835},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9940000176429749},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6290000081062317},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9390299320220947},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8799667358398438},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7965075969696045},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.5425671935081482},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5093790292739868},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48001211881637573},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3670484721660614},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.3306022584438324},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3146040737628937},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28777915239334106},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059186","descriptor_name":"Chemoradiotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.clcc.2019.04.006","doi":"https://doi.org/10.1016/j.clcc.2019.04.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clcc.2019.04.006","pdf_url":"http://www.clinical-colorectal-cancer.com/article/S1533002818304547/pdf","source":{"id":"https://openalex.org/S112974357","display_name":"Clinical Colorectal Cancer","issn_l":"1533-0028","issn":["1533-0028","1938-0674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clinical Colorectal Cancer","raw_type":"journal-article"},{"id":"pmid:31311761","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31311761","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical colorectal cancer","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:HAL:hal-03487688v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-03487688","pdf_url":"https://hal.science/hal-03487688/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Colorectal Cancer, 2019, 18, pp.200 - 208.e1. ⟨10.1016/j.clcc.2019.04.006⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.clcc.2019.04.006","doi":"https://doi.org/10.1016/j.clcc.2019.04.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clcc.2019.04.006","pdf_url":"http://www.clinical-colorectal-cancer.com/article/S1533002818304547/pdf","source":{"id":"https://openalex.org/S112974357","display_name":"Clinical Colorectal Cancer","issn_l":"1533-0028","issn":["1533-0028","1938-0674"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clinical Colorectal Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"},{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320333684","display_name":"Sanofi Pasteur","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2943333990.pdf","grobid_xml":"https://content.openalex.org/works/W2943333990.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1251438649","https://openalex.org/W1595350187","https://openalex.org/W1880063947","https://openalex.org/W1902873874","https://openalex.org/W1963729161","https://openalex.org/W1982508445","https://openalex.org/W1984350126","https://openalex.org/W1994615279","https://openalex.org/W2031268194","https://openalex.org/W2034603533","https://openalex.org/W2098499757","https://openalex.org/W2102886345","https://openalex.org/W2103418254","https://openalex.org/W2103551875","https://openalex.org/W2110154965","https://openalex.org/W2113353705","https://openalex.org/W2115153468","https://openalex.org/W2115421613","https://openalex.org/W2122117926","https://openalex.org/W2123377696","https://openalex.org/W2124886112","https://openalex.org/W2125452425","https://openalex.org/W2140183817","https://openalex.org/W2142167347","https://openalex.org/W2143743735","https://openalex.org/W2155173276","https://openalex.org/W2155492044","https://openalex.org/W2157769714","https://openalex.org/W2158709109","https://openalex.org/W2163232628","https://openalex.org/W2169925647","https://openalex.org/W2212807488","https://openalex.org/W2410989399","https://openalex.org/W2485154242","https://openalex.org/W2519654237","https://openalex.org/W2528688323","https://openalex.org/W2588058127","https://openalex.org/W2724547932","https://openalex.org/W2734330425","https://openalex.org/W4244315786","https://openalex.org/W4249822831","https://openalex.org/W4299366427","https://openalex.org/W4327766725","https://openalex.org/W6682230513"],"related_works":["https://openalex.org/W2103418254","https://openalex.org/W3106730199","https://openalex.org/W2108089475","https://openalex.org/W7128369907","https://openalex.org/W2320826325","https://openalex.org/W7164913726","https://openalex.org/W2912695313","https://openalex.org/W2809310239","https://openalex.org/W7053141142","https://openalex.org/W2020014009"],"abstract_inverted_index":{"BACKGROUND:":[0],"Recurrence":[1],"and":[2,60,83,112,137,143,154,161,171,193,198,214,241],"distant":[3],"metastases":[4],"remain":[5],"a":[6,164,251],"significant":[7],"issue":[8],"in":[9,20,80,85,109,115,134,140,145,158,166,174,195,211,221,243,262],"locally":[10],"advanced":[11],"rectal":[12],"cancer":[13],"(LARC).":[14],"Several":[15],"multimodal":[16],"strategies":[17,261],"are":[18,67],"assessed":[19],"clinical":[21],"trials.":[22],"PATIENTS":[23],"AND":[24],"METHODS:":[25],"Patients":[26],"with":[27,250],"mid/low":[28],"magnetic":[29],"resonance":[30],"imaging-defined":[31],"high-risk":[32],"LARC":[33,263],"were":[34,88,129],"randomized":[35],"to":[36,63,124,233],"arm":[37,53,81,86,110,116,135,141,146,175,212,222],"A":[38,82,111,142,160,176,197,213],"(12-week":[39],"bevacizumab":[40,226],"+":[41,227],"FOLFOX-4":[42,228],"then":[43,56,246],"bevacizumab-5-fluorouracil":[44],"[5-FU]-radiotherapy":[45],"[RT]":[46],"before":[47,185],"total":[48],"mesorectal":[49],"excision":[50],"[TME])":[51],"or":[52],"B":[54,117,162],"(bevacizumab-5-FU-RT":[55],"TME).":[57],"Long-term":[58],"efficacy":[59],"safety":[61],"up":[62],"5":[64,149],"years'":[65,150],"follow-up":[66,99],"reported.":[68],"No":[69],"comparison":[70],"between":[71],"arms":[72,159,196],"was":[73,191,204,248],"planned.":[74],"RESULTS:":[75],"Overall,":[76],"91":[77],"patients":[78,107,157],"(46":[79],"45":[84],"B)":[87],"included.":[89],"Main":[90],"results":[91],"have":[92,230],"been":[93],"presented":[94],"previously.":[95],"During":[96],"the":[97,126,167,231],"late":[98],"period":[100],"(>":[101],"4":[102,106,113],"weeks":[103],"after":[104,169,181],"surgery),":[105],"(8.7%)":[108],"(8.9%)":[114],"experienced":[118],"grade":[119],"3/4":[120],"adverse":[121],"events":[122],"related":[123],"bevacizumab;":[125],"most":[127],"frequent":[128],"2":[130,144,172],"anastomotic":[131,255],"fistulas":[132],"(both":[133],"A)":[136],"abscesses":[138],"(1":[139],"B).":[147],"At":[148],"follow-up,":[151],"9":[152],"(19.6%)":[153],"11":[155],"(24.4%)":[156],"developed":[163],"fistula":[165],"year":[168,180],"surgery,":[170],"(4.3%)":[173],"at":[177],">":[178],"1":[179],"surgery.":[182],"Most":[183],"resolved":[184],"study":[186],"end.":[187],"Five-year":[188,201],"disease-free":[189],"survival":[190,203,235],"70%":[192],"64.3%":[194],"B,":[199],"respectively.":[200],"overall":[202],"90.5%":[205],"(95%":[206,216],"confidence":[207,217],"interval,":[208,218],"76.7,":[209],"96.3)":[210],"72.7%":[215],"56.0,":[219],"83.9)":[220],"B.":[223],"CONCLUSION:":[224],"Neoadjuvant":[225],"may":[229],"potential":[232],"increase":[234],"outcomes":[236],"when":[237],"followed":[238],"by":[239],"bevacizumab-5-FU-RT":[240],"TME":[242,247],"LARC.":[244],"Bevacizumab-5-FU-RT":[245],"associated":[249],"higher-than-projected":[252],"rate":[253],"of":[254,259],"fistulas.":[256],"Further":[257],"research":[258],"neoadjuvant":[260],"is":[264],"encouraged.":[265]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-05-09T00:00:00"}